BEAM
HealthcareBeam Therapeutics Inc.
$25.16-0.43 (-1.68%)
Prev Close
$25.59
Open
$26.00
High
$26.23
Low
$24.75
Volume
1.24M
Market Cap
$2.82B
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Beam Therapeutics Inc. (BEAM) has been exclusively selling, with 0 insider purchases totaling $0.00 and 23 insider sales totaling $9.05M. The most recent insider transaction was by Ciaramella Giuseppe (officer: President), who sold $1.12M worth of shares on Feb 26, 2026. Beam Therapeutics Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $2.82B.
Buys (12M)
0
$0.00
Sells (12M)
23
$9.05M
Net Activity
Net Seller
$9.05M
Active Insiders
6
last 12 mo
BEAM Price Chart
BEAM Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026↗ | Ciaramella Giuseppe | officer: President | Sell | 35,000 | $32.00 | $1.12M | 190,216 |
| Feb 2, 2026↗ | Evans John M. | director, officer: CEO | Sell | 50,000 | $28.87 | $1.44M | 995,334 |
| Jan 29, 2026↗ | Evans John M. | CEO | Sell | 50,000 | $28.87 | $1.44M | 0 |
| Jan 26, 2026↗ | Bellon Christine | officer: Chief Legal Officer | Sell | 1,371 | $34.00 | $46.6K | 95,667 |
| Jan 26, 2026↗ | Cavanagh Bethany J | officer: SVP, Finance and Treasurer | Sell | 6,198 | $35.00 | $216.9K | 34,813 |
| Jan 22, 2026↗ | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 6,198 | $35.00 | $216.9K | 0 |
| Jan 21, 2026↗ | Cavanagh Bethany J | officer: SVP, Finance and Treasurer | Sell | 3,034 | $30.12 | $91.4K | 41,011 |
| Jan 20, 2026↗ | Bellon Christine | officer: Chief Legal Officer | Sell | 18,629 | $34.61 | $644.8K | 113,556 |
| Jan 20, 2026↗ | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 3,034 | $30.12 | $91.4K | 0 |
| Jan 15, 2026↗ | Bellon Christine | Chief Legal Officer | Sell | 18,629 | $34.61 | $644.8K | 0 |
| Jan 5, 2026↗ | Bellon Christine | officer: Chief Legal Officer | Sell | 1,254 | $27.10 | $34.0K | 115,667 |
| Jan 5, 2026↗ | Emany Sravan Kumar | officer: Chief Financial Officer | Sell | 6,294 | $27.10 | $170.6K | 73,706 |
| Dec 31, 2025↗ | Bellon Christine | Chief Legal Officer | Sell | 1,254 | $27.10 | $34.0K | 0 |
| Dec 31, 2025↗ | Emany Sravan Kumar | Chief Financial Officer | Sell | 6,294 | $27.10 | $170.6K | 0 |
| Oct 1, 2025↗ | Bellon Christine | Chief Legal Officer | Sell | 373 | $24.53 | $9.1K | 0 |
| Oct 1, 2025↗ | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 467 | $24.53 | $11.5K | 0 |
| Oct 1, 2025↗ | Evans John M. | CEO | Sell | 50,000 | $24.57 | $1.23M | 0 |
| Jul 1, 2025↗ | Simon Amy | Chief Medical Officer | Sell | 1,250 | $19.17 | $24.0K | 0 |
| Apr 1, 2025↗ | Bellon Christine | Chief Legal Officer | Sell | 5,674 | $18.35 | $104.1K | 0 |
| Apr 1, 2025↗ | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 3,015 | $18.35 | $55.3K | 0 |
| Apr 1, 2025↗ | Ciaramella Giuseppe | President | Sell | 7,434 | $18.35 | $136.4K | 0 |
| Apr 1, 2025↗ | Evans John M. | CEO | Sell | 30,663 | $18.35 | $562.7K | 0 |
| Apr 1, 2025↗ | Simon Amy | Chief Medical Officer | Sell | 30,563 | $17.92 | $547.8K | 0 |
| Feb 18, 2025↗ | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 6,287 | $35.00 | $220.0K | 0 |
| Feb 14, 2025↗ | Bellon Christine | Chief Legal Officer | Sell | 10,000 | $34.00 | $340.0K | 0 |
| Jan 30, 2025↗ | Evans John M. | CEO | Sell | 30,000 | $26.75 | $802.5K | 0 |
| Jan 2, 2025↗ | Bellon Christine | Chief Legal Officer | Sell | 1,241 | $24.68 | $30.6K | 0 |
| Jan 2, 2025↗ | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 1,117 | $24.68 | $27.6K | 0 |
| Nov 6, 2024↗ | Ciaramella Giuseppe | President | Sell | 51,110 | $26.36 | $1.35M | 0 |
| Oct 14, 2024↗ | Ciaramella Giuseppe | President | Sell | 51,110 | $26.27 | $1.34M | 0 |
| Oct 1, 2024↗ | Bellon Christine | Chief Legal Officer | Sell | 385 | $23.48 | $9.0K | 0 |
| Sep 30, 2024↗ | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 289 | $23.48 | $6.8K | 0 |
| Sep 30, 2024↗ | Evans John M. | CEO | Sell | 60,000 | $24.60 | $1.48M | 0 |
| Jul 1, 2024↗ | Simon Amy | Chief Medical Officer | Sell | 1,250 | $23.28 | $29.1K | 0 |
| Jun 27, 2024↗ | Evans John M. | CEO | Sell | 60,000 | $24.50 | $1.47M | 0 |
| Apr 1, 2024↗ | Bellon Christine | Chief Legal Officer | Sell | 3,401 | $32.12 | $109.2K | 0 |
| Apr 1, 2024↗ | Burrell Terry-Ann | Chief Financial Officer | Sell | 5,446 | $32.12 | $174.9K | 0 |
| Apr 1, 2024↗ | Ciaramella Giuseppe | President | Sell | 4,534 | $32.12 | $145.6K | 0 |
| Apr 1, 2024↗ | Evans John M. | CEO | Sell | 18,102 | $32.13 | $581.6K | 0 |
| Apr 1, 2024↗ | Simon Amy | Chief Medical Officer | Sell | 23,687 | $31.02 | $734.8K | 0 |
| Mar 28, 2024↗ | Evans John M. | CEO | Sell | 60,000 | $33.86 | $2.03M | 0 |
| Jan 31, 2024↗ | Evans John M. | CEO | Sell | 60,000 | $25.33 | $1.52M | 0 |
| Jan 3, 2024↗ | Bellon Christine | Chief Legal Officer | Sell | 1,907 | $26.42 | $50.4K | 0 |
| Nov 20, 2023↗ | Bellon Christine | Chief Legal Officer | Sell | 10,000 | $30.50 | $305.0K | 0 |
| Oct 30, 2023↗ | Simon Amy | Chief Medical Officer | Sell | 3,448 | $18.70 | $64.5K | 0 |
| Oct 2, 2023↗ | Bellon Christine | Chief Legal Officer | Sell | 388 | $22.85 | $8.9K | 0 |
| Jul 21, 2023↗ | Ciaramella Giuseppe | President and CSO | Sell | 156,530 | $32.06 | $5.02M | 0 |
| Jul 10, 2023↗ | Simon Amy | Chief Medical Officer | Sell | 391 | $30.48 | $11.9K | 0 |
| Apr 3, 2023↗ | Bellon Christine | Chief Legal Officer | Sell | 2,092 | $29.63 | $62.0K | 0 |
| Apr 3, 2023↗ | Burrell Terry-Ann | Chief Financial Officer | Sell | 4,640 | $29.74 | $138.0K | 0 |
Showing 1–50 of 75
1 / 2
BEAM Insider Buying Activity
The following table shows recent insider purchases of Beam Therapeutics Inc. (BEAM) stock reported via SEC Form 4 filings.
No insider buying activity found for BEAM in the last 12 months.
BEAM Insider Selling Activity
The following table shows recent insider sales of Beam Therapeutics Inc. (BEAM) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026↗ | Ciaramella Giuseppe | officer: President | Sell | 35,000 | $32.00 | $1.12M | 190,216 |
| Feb 2, 2026↗ | Evans John M. | director, officer: CEO | Sell | 50,000 | $28.87 | $1.44M | 995,334 |
| Jan 29, 2026↗ | Evans John M. | CEO | Sell | 50,000 | $28.87 | $1.44M | 0 |
| Jan 26, 2026↗ | Bellon Christine | officer: Chief Legal Officer | Sell | 1,371 | $34.00 | $46.6K | 95,667 |
| Jan 26, 2026↗ | Cavanagh Bethany J | officer: SVP, Finance and Treasurer | Sell | 6,198 | $35.00 | $216.9K | 34,813 |
| Jan 22, 2026↗ | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 6,198 | $35.00 | $216.9K | 0 |
| Jan 21, 2026↗ | Cavanagh Bethany J | officer: SVP, Finance and Treasurer | Sell | 3,034 | $30.12 | $91.4K | 41,011 |
| Jan 20, 2026↗ | Bellon Christine | officer: Chief Legal Officer | Sell | 18,629 | $34.61 | $644.8K | 113,556 |
| Jan 20, 2026↗ | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 3,034 | $30.12 | $91.4K | 0 |
| Jan 15, 2026↗ | Bellon Christine | Chief Legal Officer | Sell | 18,629 | $34.61 | $644.8K | 0 |
| Jan 5, 2026↗ | Bellon Christine | officer: Chief Legal Officer | Sell | 1,254 | $27.10 | $34.0K | 115,667 |
| Jan 5, 2026↗ | Emany Sravan Kumar | officer: Chief Financial Officer | Sell | 6,294 | $27.10 | $170.6K | 73,706 |
| Dec 31, 2025↗ | Bellon Christine | Chief Legal Officer | Sell | 1,254 | $27.10 | $34.0K | 0 |
| Dec 31, 2025↗ | Emany Sravan Kumar | Chief Financial Officer | Sell | 6,294 | $27.10 | $170.6K | 0 |
| Oct 1, 2025↗ | Bellon Christine | Chief Legal Officer | Sell | 373 | $24.53 | $9.1K | 0 |
| Oct 1, 2025↗ | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 467 | $24.53 | $11.5K | 0 |
| Oct 1, 2025↗ | Evans John M. | CEO | Sell | 50,000 | $24.57 | $1.23M | 0 |
| Jul 1, 2025↗ | Simon Amy | Chief Medical Officer | Sell | 1,250 | $19.17 | $24.0K | 0 |
| Apr 1, 2025↗ | Bellon Christine | Chief Legal Officer | Sell | 5,674 | $18.35 | $104.1K | 0 |
| Apr 1, 2025↗ | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 3,015 | $18.35 | $55.3K | 0 |
| Apr 1, 2025↗ | Ciaramella Giuseppe | President | Sell | 7,434 | $18.35 | $136.4K | 0 |
| Apr 1, 2025↗ | Evans John M. | CEO | Sell | 30,663 | $18.35 | $562.7K | 0 |
| Apr 1, 2025↗ | Simon Amy | Chief Medical Officer | Sell | 30,563 | $17.92 | $547.8K | 0 |
| Feb 18, 2025↗ | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 6,287 | $35.00 | $220.0K | 0 |
| Feb 14, 2025↗ | Bellon Christine | Chief Legal Officer | Sell | 10,000 | $34.00 | $340.0K | 0 |
| Jan 30, 2025↗ | Evans John M. | CEO | Sell | 30,000 | $26.75 | $802.5K | 0 |
| Jan 2, 2025↗ | Bellon Christine | Chief Legal Officer | Sell | 1,241 | $24.68 | $30.6K | 0 |
| Jan 2, 2025↗ | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 1,117 | $24.68 | $27.6K | 0 |
| Nov 6, 2024↗ | Ciaramella Giuseppe | President | Sell | 51,110 | $26.36 | $1.35M | 0 |
| Oct 14, 2024↗ | Ciaramella Giuseppe | President | Sell | 51,110 | $26.27 | $1.34M | 0 |
| Oct 1, 2024↗ | Bellon Christine | Chief Legal Officer | Sell | 385 | $23.48 | $9.0K | 0 |
| Sep 30, 2024↗ | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 289 | $23.48 | $6.8K | 0 |
| Sep 30, 2024↗ | Evans John M. | CEO | Sell | 60,000 | $24.60 | $1.48M | 0 |
| Jul 1, 2024↗ | Simon Amy | Chief Medical Officer | Sell | 1,250 | $23.28 | $29.1K | 0 |
| Jun 27, 2024↗ | Evans John M. | CEO | Sell | 60,000 | $24.50 | $1.47M | 0 |
| Apr 1, 2024↗ | Bellon Christine | Chief Legal Officer | Sell | 3,401 | $32.12 | $109.2K | 0 |
| Apr 1, 2024↗ | Burrell Terry-Ann | Chief Financial Officer | Sell | 5,446 | $32.12 | $174.9K | 0 |
| Apr 1, 2024↗ | Ciaramella Giuseppe | President | Sell | 4,534 | $32.12 | $145.6K | 0 |
| Apr 1, 2024↗ | Evans John M. | CEO | Sell | 18,102 | $32.13 | $581.6K | 0 |
| Apr 1, 2024↗ | Simon Amy | Chief Medical Officer | Sell | 23,687 | $31.02 | $734.8K | 0 |
| Mar 28, 2024↗ | Evans John M. | CEO | Sell | 60,000 | $33.86 | $2.03M | 0 |
| Jan 31, 2024↗ | Evans John M. | CEO | Sell | 60,000 | $25.33 | $1.52M | 0 |
| Jan 3, 2024↗ | Bellon Christine | Chief Legal Officer | Sell | 1,907 | $26.42 | $50.4K | 0 |
| Nov 20, 2023↗ | Bellon Christine | Chief Legal Officer | Sell | 10,000 | $30.50 | $305.0K | 0 |
| Oct 30, 2023↗ | Simon Amy | Chief Medical Officer | Sell | 3,448 | $18.70 | $64.5K | 0 |
| Oct 2, 2023↗ | Bellon Christine | Chief Legal Officer | Sell | 388 | $22.85 | $8.9K | 0 |
| Jul 21, 2023↗ | Ciaramella Giuseppe | President and CSO | Sell | 156,530 | $32.06 | $5.02M | 0 |
| Jul 10, 2023↗ | Simon Amy | Chief Medical Officer | Sell | 391 | $30.48 | $11.9K | 0 |
| Apr 3, 2023↗ | Bellon Christine | Chief Legal Officer | Sell | 2,092 | $29.63 | $62.0K | 0 |
| Apr 3, 2023↗ | Burrell Terry-Ann | Chief Financial Officer | Sell | 4,640 | $29.74 | $138.0K | 0 |
BEAM Insiders
Similar Stocks to BEAM
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$536.12+0.97%
$23.50B
MRNA
Moderna, Inc.
$52.56-1.89%
$20.76B
ROIV
Roivant Sciences Ltd.
$28.06-1.44%
$20.08B
RPRX
Royalty Pharma plc
$45.65-0.57%
$19.56B